Delursan


Indications and Reactions:

Role Indications Reactions
Primary
Hepatic Fibrosis 100.0%
Weight Decreased 100.0%
Secondary
Product Used For Unknown Indication 65.1%
Prophylaxis 11.8%
Cholestasis 2.5%
Hypertension 1.8%
Immunosuppression 1.8%
Insomnia 1.8%
Prevention 1.8%
Drug Exposure During Pregnancy 1.6%
Anxiety 1.4%
Atrial Fibrillation 1.4%
Hypothyroidism 1.4%
Vitamin B12 Deficiency 1.4%
Hiv Infection 1.1%
Liver Transplant 1.1%
Autoimmune Hepatitis 0.9%
Bone Marrow Conditioning Regimen 0.9%
Drug Use For Unknown Indication 0.7%
Prophylaxis Against Diarrhoea 0.7%
Anaemia 0.5%
Ankylosing Spondylitis 0.5%
Toxic Epidermal Necrolysis 32.4%
Thrombotic Microangiopathy 17.6%
Dysmorphism 11.8%
Intra-abdominal Haematoma 5.9%
Haematotoxicity 2.9%
Neonatal Hypotension 2.9%
Normochromic Normocytic Anaemia 2.9%
Purpura 2.9%
Red Blood Cell Schistocytes Present 2.9%
Renal Failure 2.9%
Transaminases Increased 2.9%
Transient Ischaemic Attack 2.9%
Visual Acuity Reduced 2.9%
Vomiting 2.9%
Weight Decreased 2.9%
Concomitant
Product Used For Unknown Indication 42.6%
Drug Use For Unknown Indication 9.3%
Prophylaxis 6.5%
Hepatitis C 6.1%
Bone Marrow Conditioning Regimen 5.4%
Diabetes Mellitus 4.4%
Acute Myeloid Leukaemia 4.3%
Hypertension 2.9%
Prophylaxis Against Transplant Rejection 2.5%
Multiple Myeloma 2.4%
Liver Transplant 2.0%
Pain 1.8%
Antibiotic Prophylaxis 1.3%
Bile Duct Stone 1.2%
Bipolar Disorder 1.2%
Crohn's Disease 1.2%
Haemolysis 1.2%
Pneumonia 1.2%
Pulmonary Arterial Hypertension 1.2%
Sedation 1.2%
Cytolytic Hepatitis 11.5%
Renal Failure Acute 11.5%
Pancreatitis Acute 6.4%
Porphyria Non-acute 6.4%
Hepatitis 5.1%
Hepatitis Acute 5.1%
Pyrexia 5.1%
Septic Shock 5.1%
Vomiting 5.1%
Bone Marrow Failure 3.8%
Hallucination 3.8%
Hypersensitivity 3.8%
Renal Failure 3.8%
Sepsis 3.8%
Staphylococcal Infection 3.8%
Thrombocytopenia 3.8%
Venoocclusive Liver Disease 3.8%
Agranulocytosis 2.6%
Cardiac Arrest 2.6%
Circulatory Collapse 2.6%

Drug Data